The recent FDA approval of the IsoPSA blood test may represent a notable advancement in prostate cancer screening and diagnosis. Developed by Cleveland Diagnostics, the in vitro diagnostic instrument ...

THIS YEAR, IT’S estimated that nearly 300,000 new prostate cancer cases will be diagnosed. While there’s no single test to detect prostate cancer, doctors commonly use the prostate-specific antigen ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Scientists writing in the New England Journal of Medicine said a genetic test using saliva is more accurate than a PSA blood test to assess prostate cancer risk. A new at-home spit test is better at ...

Currently, the UK lacks a national, population-wide screening programme for the disease, despite persistent calls from cancer charities and prominent figures for increased testing, particularly for ...

Investigators analyzed exfoliated cells in urine specimens to identify 50 candidate RNAs for prostate cancer detection.

Campaigners are calling for a national prostate screening programme to prevent deaths and save money Prostate cancer is the most common cancer in men in the UK, with approximately 55,000 new cases ...

Early detection of prostate cancer remains a major clinical challenge due to the lack of reliable biomarkers, despite the disease being highly treatable when caught in its early stages. Now, ...

IRVINE, Calif., Jan. 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (BMRA) (Nasdaq: BMRA), a global provider of innovative diagnostic solutions, is proud to announce that its Fortel ® Prostate Specific ...

Share on Pinterest Scientists are working on developing a urine test to detect prostate cancer. Anchalee Phanmaha/Getty Images Early detection of prostate cancer remains a major clinical challenge due ...